Summary

The MAD has been an official Affymetrix GeneChips® service provider since 2002. The patented Affymetrix GeneChips® platform is the world's leading system in genome-wide expression analysis. More than one million different gene-specific oligonucleotides are synthesized in situ directly on the chip surface using a photolithographic procedure.

Strengths of the Affymetrix GeneChip® technology:

• minimal error due to closed system
• robost results due to the design of multiple probes per gene
• maximum control due to multiple quality controls
• high reproducibility due to highly standardized protocols
• fast data processing due to a direct link to comprehensive database